Physician profile
Rage Geringer
NPI 1447757349
$7,457.66
in general payments reported to CMS, 2019-2025
17 companies · $4,049 in 2025
The $4,049 reported for 2025 was more than what 86% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $191 · 2023: $395 · 2024: $2,823 · 2025: $4,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,344 · Travel and Lodging: $2,906 · Education: $16.24.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,344.02 |
| Travel and Lodging | $2,906.18 |
| Education | $16.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noah Medical Corporation | $5,116.75 | 2024-2025 | Galaxy |
| Astrazeneca Pharmaceuticals Lp | $920.67 | 2023-2025 | Fasenra, Breztri, Airsupra |
| Genzyme Corporation | $313.00 | 2024-2025 | |
| Astellas Pharma US INC | $191.22 | 2021 | |
| Insmed, INC. | $162.93 | 2025 | Arikayce, Brinsupri |
| Grifols USA, LLC | $154.82 | 2023-2025 | Prolastin-C Liquid, Gamunex-C |
| Amgen INC. | $104.17 | 2023-2025 | Tezspire |
| Glaxosmithkline, LLC. | $89.56 | 2024-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $77.77 | 2024-2025 | Jascayd, Ofev |
| Mylan Specialty L.P. | $75.91 | 2024 | Yupelri |
| Viatris Specialty LLC | $58.14 | 2025 | Yupelri |
| Ucb, INC. | $49.69 | 2025 | Bimzelx |
| Fisher & Paykel Healthcare INC | $44.98 | 2025 | Fisher & Paykel Healthcare |
| Regeneron Healthcare Solutions, INC. | $31.55 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $23.24 | 2025 | Winrevair |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $22.20 | 2025 | Vest Therapy Und |
| Bayer Healthcare Pharmaceuticals INC. | $21.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rage Geringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.